Kong Yan-guo, Su Chang-bao, Ren Zu-yuan, Wang Ren-zhi
Laboratory of Neurosurgery, PUMC Hospital, CAMS, PUMC, Beijing 100730, China.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2002 Aug;24(4):427-9.
To investigate effect of the serum concentration of epidermal growth factor receptor (EGFR) in the pre- and postoperative peripheral blood in patients with meningiomas.
Using ELISA, the EGFR concentration were measured in the pre- and postoperative serum in 53 patients with meningiomas. In this study, the patients were divided into preoperative group, postoperative group (including 42 total resection, 11 subtotal resection), and 28 healthy control.
In 53 patients with meningiomas, concentration of preoperative serum EGFR was (352.93 +/- 66.18) fmol/ml, to show higher than control group (159.11 +/- 40.50) fmol/ml (P < 0.0001); Concentration of postoperative serum EGFR was (220.74 +/- 70.63) fmol/ml, to show lower than preoperative group (P < 0.001). Including in 42 patients with meningomas by total resection, serum EGFRs of the 38 patients were decreased (191.20 +/- 32.13) fmol/ml, the 4 patients with peritumoral edema were decreased (248.75 +/- 10.31) fmol/ml, to show lower than preoperative group (P < 0.001); the 11 patients with subtotal resection were decreased (322.14 +/- 89.53) fmol/ml, not to show different than preoperative group (P < 0.05).
In 92.16% patients with meningiomas, the more poison of the tumor is resected, the less the serum EGFR concentration is detected postoperatively, while the total resection of mangionmas resulted in a lowest level of EGFR. These results support the concept that human meningiomas may be autocrine EGFRs. The measurement of serum EGFR can be useful to patients with meningiomas for follow-up after surgery.
探讨脑膜瘤患者术前及术后外周血中表皮生长因子受体(EGFR)血清浓度的变化。
采用酶联免疫吸附测定法(ELISA)检测53例脑膜瘤患者术前及术后血清中EGFR的浓度。本研究将患者分为术前组、术后组(包括42例全切除患者、11例次全切除患者)和28例健康对照组。
53例脑膜瘤患者术前血清EGFR浓度为(352.93±66.18)fmol/ml,高于对照组(159.11±40.50)fmol/ml(P<0.0001);术后血清EGFR浓度为(220.74±70.63)fmol/ml,低于术前组(P<0.001)。其中42例全切除的脑膜瘤患者中,38例患者血清EGFR降至(191.20±32.13)fmol/ml,4例合并瘤周水肿患者降至(248.75±10.31)fmol/ml,均低于术前组(P<0.001);11例次全切除患者血清EGFR降至(322.14±89.53)fmol/ml,与术前组相比差异无统计学意义(P>0.05)。
92.16%的脑膜瘤患者肿瘤切除越彻底,术后血清EGFR浓度越低,全切除患者术后EGFR水平最低。这些结果支持人脑膜瘤可能存在EGFR自分泌的观点。血清EGFR检测有助于脑膜瘤患者术后随访。